礼来以最高38亿美元收购AtaiBeckley,进军迷幻药物领域

路透中文
Jul 16
<a href="https://laohu8.com/S/LLY">礼来</a>以最高38亿美元收购AtaiBeckley,进军迷幻药物领域

路透7月16日 - 礼来公司(Eli Lilly, LLY.N)周四表示,将以最高38亿美元的价格收购迷幻药物开发商AtaiBeckley(ATAI.O),从而加入开发用于治疗抑郁症及其他精神健康障碍的迷幻疗法的竞争。

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10